Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
Public ClinicalTrials.gov record NCT00924638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CRYptogenic STroke And underLying AF Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The 2006 American Heart Association / American Stroke Association Council on Stroke Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic recommended that patients with cryptogenic stroke take antithrombotic drugs (i.e. aspirin) in order to prevent a second stroke. When a stroke patient is found to have atrial fibrillation (AF), the guidelines recommend oral anticoagulation due to its superior efficacy over aspirin for stroke prevention. Physicians can best optimize the use of medicines only if they can precisely and correctly diagnose a patient's AF. The purpose of this study is to evaluate the time to first AF by 6 months' continuous rhythm monitoring versus control treatment in subjects with a recent cryptogenic stroke or Transient Ischemic Attack (TIA) without history of AF.
Study identification
- NCT ID
- NCT00924638
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 447 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2009 (Type not available)
- Primary completion
- May 2013 (Actual)
- Completion
- May 2013 (Actual)
- Last update posted
- Jul 28, 2014
2009 – 2013
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| El Camino Hospital | Mountain View | California | — | — |
| South Denver Cardiology / Swedish Medical Center | Denver | Colorado | — | — |
| Northwestern Memorial Hospital | Chicago | Illinois | — | — |
| Iowa Heart / Ruan Neurology | Des Moines | Iowa | — | — |
| Louisville Cardiology | Louisville | Kentucky | — | — |
| Cardiology Associates Research, LLC | Tupelo | Mississippi | — | — |
| Mid America Heart Institute / St. Lukes Hospital | Kansas City | Missouri | — | — |
| Washington University Medical School | St Louis | Missouri | — | — |
| Hackensack University Medical Center | Hackensack | New Jersey | — | — |
| Forsyth Medical Center | Winston-Salem | North Carolina | — | — |
| Ohio Health Research | Columbus | Ohio | — | — |
| Sacred Heart Medical Center | Eugene | Oregon | — | — |
| Central Bucks Specialists / Doylestown Hospital | Doylestown | Pennsylvania | — | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | — | — |
| Lankenau | Wynnewood | Pennsylvania | — | — |
| Greenville Hospital System Cardiology/Cardiovascular Research | Greenville | South Carolina | — | — |
| St. Thomas Research Institute | Nashville | Tennessee | — | — |
| Baylor Research Institute | Dallas | Texas | — | — |
| University of Texas - Southwestern Medical Center | Dallas | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00924638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2014 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00924638 live on ClinicalTrials.gov.